Literature DB >> 33115246

Natural Molecules Targeting Thioredoxin System and Their Therapeutic Potential.

Junmin Zhang1,2, Dongzhu Duan1,2, Alsiddig Osama1,2, Jianguo Fang1,2.   

Abstract

Significance: Thioredoxin (Trx) and thioredoxin reductase are two core members of the Trx system. The system bridges the gap between the universal reducing equivalent NADPH and various biological molecules and plays an essential role in maintaining cellular redox homeostasis and regulating multiple cellular redox signaling pathways. Recent Advance: In recent years, the Trx system has been well documented as an important regulator of many diseases, especially tumorigenesis. Thus, the development of potential therapeutic molecules targeting the system is of great significance for disease treatment. Critical Issues: We herein first discuss the physiological functions of the Trx system and the role that the Trx system plays in various diseases. Then, we focus on the introduction of natural small molecules with potential therapeutic applications, especially the anticancer activity, and review their mechanisms of pharmacological actions via interfering with the Trx system. Finally, we further discuss several natural molecules that harbor therapeutic potential and have entered different clinical trials. Future Directions: Further studies on the functions of the Trx system in multiple diseases will not only improve our understanding of the pathogenesis of many human disorders but also help develop novel therapeutic strategies against these diseases. Antioxid. Redox Signal. 34, 1083-1107.

Entities:  

Keywords:  cancer therapy; natural products; oxidative stress; redox regulation; thioredoxin

Mesh:

Substances:

Year:  2020        PMID: 33115246     DOI: 10.1089/ars.2020.8213

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  7 in total

1.  Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis.

Authors:  Mengyue You; Fan Wu; Meilin Gao; Mengyue Chen; Shu Zeng; Yang Zhang; Wei Zhao; Danyang Li; Li Wei; Xiong Z Ruan; Yaxi Chen
Journal:  Redox Biol       Date:  2022-10-07       Impact factor: 10.787

2.  Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma.

Authors:  Zhongren Xu; Jianqiang Xu; Shibo Sun; Wei Lin; Yongming Li; Qiuyue Lu; Fuwei Li; Zhibin Yang; Yunlong Lu; Wukun Liu
Journal:  Redox Biol       Date:  2022-05-28       Impact factor: 10.787

3.  A Fluorescent Probe to Detect Quick Disulfide Reductase Activity in Bacteria.

Authors:  Ying Zhao; Xin Zuo; Shuang Liu; Wenjun Qian; Xuewen Tang; Jun Lu
Journal:  Antioxidants (Basel)       Date:  2022-02-13

Review 4.  Survey of Molecular Mechanisms of Hyperbaric Oxygen in Tissue Repair.

Authors:  Joerg Lindenmann; Christian Smolle; Lars-Peter Kamolz; Freyja Maria Smolle-Juettner; Wolfgang F Graier
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

5.  Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically.

Authors:  Jan G Felber; Lena Poczka; Karoline C Scholzen; Lukas Zeisel; Martin S Maier; Sander Busker; Ulrike Theisen; Christina Brandstädter; Katja Becker; Elias S J Arnér; Julia Thorn-Seshold; Oliver Thorn-Seshold
Journal:  Nat Commun       Date:  2022-04-01       Impact factor: 14.919

Review 6.  Essential Roles of Peroxiredoxin IV in Inflammation and Cancer.

Authors:  Pratik Thapa; Na Ding; Yanning Hao; Aziza Alshahrani; Hong Jiang; Qiou Wei
Journal:  Molecules       Date:  2022-10-02       Impact factor: 4.927

7.  Discovery of hydroxytyrosol as thioredoxin reductase 1 inhibitor to induce apoptosis and G1/S cell cycle arrest in human colorectal cancer cells via ROS generation.

Authors:  Sheng-Peng Zhang; Ji Zhou; Qing-Zhu Fan; Xiao-Mei Lv; Tian Wang; Fan Wang; Yang Chen; Sen-Yan Hong; Xiao-Ping Liu; Bing-Song Xu; Lei Hu; Chao Zhang; Ye-Ming Zhang
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.